Unexpected complete recovery of a patient with severe tick-borne encephalitis treated with favipiravir.

We report a case of tick-borne encephalitis (TBE) in a 22-year-old man, who was admitted to the Medical University of Vienna hospital with severe meningoencephalitis, unresponsive and dependent on a respirator. He had given a history of a recent tick bite, but because he had previously received a full course of vaccination against TBE, West Nile virus infection was suspected. Because the antiviral drug favipiravir has been reported to be active against WNV, therapy was initiated, and continued even after a diagnosis of TBE was confirmed, due to significant improvement of symptoms. Within days, the patient's symptoms resolved, and he was discharged after complete recovery at 15 days after onset. Although this single case does not permit any conclusion as to the role of favipiravir in the favorable outcome, it suggests that the drug should be further evaluated in laboratory animal models and in appropriate clinical settings.
PMID: 33058928 [PubMed - as supplied by publisher]

Source: Antiviral Research - October 12, 2020 Category: Virology Authors: Bologheanu R, Schubert L, Thurnher M, Schiefer J, Santonja I, Holzmann H, Österreicher Z, Tobudic S, Winkler S, Faybik P, Steininger C, Thalhammer F Tags: Antiviral Res Source Type: research